KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Change in Inventory (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Change in Inventory for 14 consecutive years, with -$338000.0 as the latest value for Q1 2026.

  • For Q1 2026, Change in Inventory rose 66.53% year-over-year to -$338000.0; the TTM value through Mar 2026 reached $14.3 million, up 214.61%, while the annual FY2025 figure was $13.7 million, 169.65% up from the prior year.
  • Change in Inventory hit -$338000.0 in Q1 2026 for Ionis Pharmaceuticals, up from -$926000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $13.5 million in Q2 2025 and bottomed at -$4.2 million in Q2 2022.
  • Average Change in Inventory over 5 years is $914705.9, with a median of -$271000.0 recorded in 2024.
  • Year-over-year, Change in Inventory tumbled 430.77% in 2022 and then skyrocketed 1590.72% in 2025.
  • Ionis Pharmaceuticals' Change in Inventory stood at -$1.2 million in 2022, then rose by 2.83% to -$1.1 million in 2023, then soared by 545.58% to $5.0 million in 2024, then crashed by 118.36% to -$926000.0 in 2025, then soared by 63.5% to -$338000.0 in 2026.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$338000.0, -$926000.0, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.